$10.96
0.0850.78%
Last update: Dec 16, 3:22 PM
Comments
Loading...
Amicus Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:FOLD | Benzinga
Amicus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 18
EPS Estimate
$0.130
Quarterly Revenue Estimate
$179.73M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$598.70M
Analyze the earnings history of Amicus Therapeutics using advanced sorting and filters.
Amicus Therapeutics (FOLD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $0.17 | $0.09 | 88.9 % |
| Q2 | 2025-07-31 | $0.01 | $-0.01 | 200.0 % |
| Q1 | 2025-05-01 | $0.03 | $0.08 | -62.5 % |
| Q4 | 2025-02-19 | $0.09 | $0.09 | 0.00 % |
Amicus Therapeutics (FOLD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $169.06M | $165.33M | 2.26 % |
| Q2 | 2025-07-31 | $154.69M | $147.01M | 5.22 % |
| Q1 | 2025-05-01 | $125.20M | $136.35M | -8.18 % |
| Q4 | 2025-02-19 | $149.71M | $147.87M | 1.24 % |
FAQ
When is Amicus Therapeutics (NASDAQ:FOLD) reporting earnings?
Amicus Therapeutics (FOLD) is scheduled to report earnings on February 18, 2026. The last reported earnings were for reported on November 4, 2025 for Q3.
What were the latest earnings per share (EPS) for Amicus Therapeutics (NASDAQ:FOLD)?
The Actual EPS was $0.17, which beat the estimate of $0.09.
What were Amicus Therapeutics’s (NASDAQ:FOLD) revenues?
The Actual Revenue was $169.1M, which beat the estimate of $165.3M.
Browse earnings estimates, EPS, and revenue on all stocks.
